Table 3.
The expression of CD24 protein and clinicopathological features of retinoblastoma tissues with low risk of extraocular relapse.
| Case no. | Age/sex | Clinicopathological features | CD24 positivity (%) |
|---|---|---|---|
| 1 | 22 mon/M | OD: WD | 0 |
| 2 | 3/M | OS: WD | 10 |
| 3 | 3 mon/F | OS: PD, Pre Lam ON Inv | 30 |
| 4 | 8/F | OD: PD, Pre Lam ON Inv | 60 |
| 5 | 1 mon/F | OD: PD, Pre Lam ON Inv | 60 |
| 6 | 5/F | OD: MD, Focal Ch, Pre Lam ON Inv | 90 |
| 7 | 4/F | OD: MD, Focal Ch Inv | 50 |
| 8 | 2/F | OD: WD, Pre Lam ON Inv | 70 |
| 9 | 3/F | OD: WD, Focal Ch, Pre Lam ON Inv | 50 |
| 10 | 2/M | OS: PD, Focal Ch Inv | 80 |
| 11 | 3/M | OD: WD, Focal Ch Inv | 60 |
| 12 | 3/M | OS: PD | 0 |
| 13 | 5/M | OS: PD | 0 |
| 14 | 1/F | OD: WD | 50 |
| 15 | 3/F | OS: PD | 0 |
| 16 | 4 mon/M | OS: PD | 0 |
| 17 | 2 mon/M | OS: WD | 0 |
| 18 | 2/M | OD: PD | 40 |
| 19 | 2/M | OD: MD | 10 |
| 20 | 16 mon/M | OS: PD, Pre Lam ON Inv | 70 |
| 21 | 6 mon/M | OS: PD | 30 |
| 22 | 2/M | OD: WD | 60 |
| 23 | 20 mon/M | OD: WD | 0 |
| 24 | 23 mon/M | OS: PD | 50 |
| 25 | 3 mon/M | OD: PD | 0 |
| 26 | 1/M | OS: WD | 0 |
| 27 | 5 mon/M | OD: WD | 30 |
| 28 | 1 mon/M | OS: WD | 20 |
| 29 | 3/M | OS: PD | 0 |
| 30 | 11 mon/M | OD: MD | 10 |
| 31 | 5/M | OS: MD | 0 |
| 32 | 2/F | OS: PD | 20 |
| 33 | 1/M | OS: MD | 0 |
| 34 | 4 mon/M | OD: MD | 0 |
| 35 | 5/M | OS: PD, Pre Lam ON Inv | 60 |
Note: mon: months; M: male; F: female; OD: right eye; OS: left eye; PD: poorly differentiated; MD: moderately differentiated; WD: well differentiated; UL: unilateral disease; BL: bilateral disease; Focal Ch Inv: focal invasion of tumor cells into choroids; Pre Lam ON Inv: pre-laminar invasion of optic nerve.